Pivotal Bioventure Partners Fund I U.g.p. Ltd - Net Worth and Insider Trading
Pivotal Bioventure Partners Fund I U.g.p. Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pivotal Bioventure Partners Fund I U.g.p. Ltd owns 2 companies in total, including Inozyme Pharma Inc (INZY) , and Entasis Therapeutics Holdings Inc (ETTX) .
Insider Ownership Summary of Pivotal Bioventure Partners Fund I U.g.p. Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2023-08-01 | director |
| ETTX | Entasis Therapeutics Holdings Inc | 2018-09-25 | 10 percent owner |
Pivotal Bioventure Partners Fund I U.g.p. Ltd Trading Performance
Pivotal Bioventure Partners Fund I U.g.p. Ltd Ownership Network
Ownership Network List of Pivotal Bioventure Partners Fund I U.g.p. Ltd
Ownership Network Relation of Pivotal Bioventure Partners Fund I U.g.p. Ltd
Pivotal Bioventure Partners Fund I U.g.p. Ltd Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Pivotal Bioventure Partners Fund I U.g.p. Ltd is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Pivotal Bioventure Partners Fund I U.g.p. Ltd made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Pivotal Bioventure Partners Fund I U.g.p. Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Pivotal Bioventure Partners Fund I U.g.p. Ltd. You might contact Pivotal Bioventure Partners Fund I U.g.p. Ltd via mailing address: 501 Second Street, Suite 200, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
